Gene · 94241
Papers1,722
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,722
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single Nucleus Sequencing of Human Colon Myenteric Plexus-Associated Visceral Smooth Muscle Cells, Platelet Derived Growth Factor Receptor Alpha Cells, and Interstitial Cells of Cajal. | Gastro Hep Adv | 2023 | 37206377 | PubTator, text mining | PubMed |
| In Silico Analysis of MicroRNA Expression Data in Liver Cancer. | Cancer Inform | 2023 | 37200943 | PubTator, text mining | PubMed |
| PARP2 poly(ADP-ribosyl)ates nuclear factor erythroid 2-related factor 2 (NRF2) affecting NRF2 subcellular localization. | Sci Rep | 2023 | 37188809 | PubTator, text mining | PubMed |
| Pancreatic cancer-derived small extracellular vesical ezrin activates fibroblasts to exacerbate cancer metastasis through STAT3 and YAP-1 signaling pathways. | Mol Oncol | 2023 | 37171030 | PubTator, text mining | PubMed |
| Isolation and Characterization of a Salt Inducible Promoter from Chlorella vulgaris PKVL7422. | J Microbiol Biotechnol | 2023 | 37164686 | PubTator, text mining | PubMed |
| Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis. | Front Mol Biosci | 2023 | 37152902 | PubTator, text mining | PubMed |
| Bromodomain protein BRD8 regulates cell cycle progression in colorectal cancer cells through a TIP60-independent regulation of the pre-RC complex. | iScience | 2023 | 37123243 | PubTator, text mining | PubMed |
| Extracellular Vesicles (EVs) in Tumor Diagnosis and Therapy. | Technol Cancer Res Treat | 2023 | 37122245 | PubTator, text mining | PubMed |
| Regulation of Host Defense Peptide Synthesis by Polyphenols. | Antibiotics (Basel) | 2023 | 37107022 | PubTator, text mining | PubMed |
| Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing. | Stem Cell Res Ther | 2023 | 37101197 | PubTator, text mining | PubMed |
| An Antibody Targeting Fibroblast Activation Protein Simultaneously Fused to Interleukin-2 and Tumor Necrosis Factor Selectively Localizes to Neoplastic Lesions. | Antibodies (Basel) | 2023 | 37092450 | PubTator, text mining | PubMed |
| Personalized regenerative strategies and molecular diagnosis for in vitro fertilization success: a case report. | Oxf Med Case Reports | 2023 | 37091684 | PubTator, text mining | PubMed |
| Current Knowledge about the Impact of Microgravity on Gene Regulation. | Cells | 2023 | 37048115 | PubTator, text mining | PubMed |
| ceRNA network construction and identification of hub genes as novel therapeutic targets for age-related cataracts using bioinformatics. | PeerJ | 2023 | 36987450 | PubTator, text mining | PubMed |
| Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer? | Int J Mol Sci | 2023 | 36982898 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Biomarkers in Head and Neck Squamous Cell Carcinoma: From Diagnosis to Disease-Free Survival. | Cancers (Basel) | 2023 | 36980712 | PubTator, text mining | PubMed |
| The Role of Exosomes in Pancreatic Ductal Adenocarcinoma Progression and Their Potential as Biomarkers. | Cancers (Basel) | 2023 | 36980662 | PubTator, text mining | PubMed |
| Integrative Analyses Reveal the Anticancer Mechanisms and Sensitivity Markers of the Next-Generation Hypomethylating Agent NTX-301. | Cancers (Basel) | 2023 | 36980623 | PubTator, text mining | PubMed |
| Bioinformatic miRNA-mRNAs Analysis Revels to miR-934 as a Potential Regulator of the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer. | Cells | 2023 | 36980175 | PubTator, text mining | PubMed |
| The melatonin receptor 1B gene links circadian rhythms and type 2 diabetes mellitus: an evolutionary story. | Ann Med | 2023 | 36974476 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/94241/papers?page=9